These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 2876570

  • 1. Reduction of pituitary size by the somatostatin analogue SMS 201-995 in a patient with an islet cell tumour secreting growth hormone releasing factor.
    Wilson DM, Hoffman AR.
    Acta Endocrinol (Copenh); 1986 Sep; 113(1):23-8. PubMed ID: 2876570
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.
    Thorner MO, Perryman RL, Cronin MJ, Rogol AD, Draznin M, Johanson A, Vale W, Horvath E, Kovacs K.
    J Clin Invest; 1982 Nov; 70(5):965-77. PubMed ID: 6290540
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical evaluation of SMS 201-995. Long-term treatment in gut neuroendocrine tumours, efficacy of oral administration, and possible use in non-tumoural inappropriate TSH hypersecretion.
    Williams G, Anderson JV, Williams SJ, Bloom SR.
    Acta Endocrinol Suppl (Copenh); 1987 Nov; 286():26-36. PubMed ID: 2892335
    [Abstract] [Full Text] [Related]

  • 6. The sensitivity of growth hormone and prolactin secretion to the somatostatin analogue SMS 201-995 in patients with prolactinomas and acromegaly.
    Lamberts SW, Zweens M, Klijn JG, van Vroonhoven CC, Stefanko SZ, Del Pozo E.
    Clin Endocrinol (Oxf); 1986 Aug; 25(2):201-12. PubMed ID: 2878748
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF, van Liessum PA, Smals AG, van Gennep JA, Benraad TJ, Kloppenborg PW.
    Acta Endocrinol Suppl (Copenh); 1987 Aug; 286():9-18. PubMed ID: 2892339
    [Abstract] [Full Text] [Related]

  • 12. The effect of minisomatostatin on anomalous growth hormone responses in acromegaly.
    Pieters GF, Smals AE, Smals AG, von Gennep JA, Kloppenborg PW.
    Acta Endocrinol (Copenh); 1987 Apr; 114(4):537-42. PubMed ID: 2883797
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptine.
    Chiodini PG, Cozzi R, Dallabonzana D, Oppizzi G, Verde G, Petroncini M, Liuzzi A, del Pozo E.
    J Clin Endocrinol Metab; 1987 Mar; 64(3):447-53. PubMed ID: 2880861
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Octreotide suppresses both growth hormone (GH) and GH-releasing hormone (GHRH) in acromegaly due to ectopic GHRH secretion.
    Moller DE, Moses AC, Jones K, Thorner MO, Vance ML.
    J Clin Endocrinol Metab; 1989 Feb; 68(2):499-504. PubMed ID: 2493033
    [Abstract] [Full Text] [Related]

  • 18. Recurrent acromegaly resulting from ectopic growth hormone gene expression by a metastatic pancreatic tumor.
    Ezzat S, Ezrin C, Yamashita S, Melmed S.
    Cancer; 1993 Jan 01; 71(1):66-70. PubMed ID: 8416728
    [Abstract] [Full Text] [Related]

  • 19. Acromegaly due to ectopic growth hormone-releasing hormone secretion by a bronchial carcinoid tumour. Dynamic hormonal responses to various stimuli.
    Glikson M, Gil-Ad I, Galun E, Dresner R, Zilberman S, Halperin Y, Okon E, Laron Z, Rubinow A.
    Acta Endocrinol (Copenh); 1991 Oct 01; 125(4):366-71. PubMed ID: 1683501
    [Abstract] [Full Text] [Related]

  • 20. Morphology of a GHRH producing pancreatic islet cell tumour causing acromegaly.
    Saeger W, Schulte HM, Klöppel G.
    Virchows Arch A Pathol Anat Histopathol; 1986 Oct 01; 409(4):547-54. PubMed ID: 3016979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.